Geometry Dash APK Hill Climb Racing APK
77.6 F
New York
Tuesday, June 15, 2021

CytoDyn Inc (OTCMKTS:CYDY) Moves Above The Trading Range: Buy, Sell, or Hold?

Must read

Bombardier, Inc. (OTCMKTS:BDRBF) Continues to Gain Momentum and Strength

Many stocks have managed to record significant gains in recent months and one that often flies under the radar is Bombardier,...

Grayscale Bitcoin Trust (Btc) (GBTC) Makes Big Move As Bitcoin Goes Wild

Bitcoin, the world’s biggest cryptocurrency by market cap, has been in the middle of a remarkable rally for the past few months...

Voyager Digital Ltd (OTCMKTS:VYGVF) Hits All-Time High on Download News

The remarkable rally enjoyed by several crypto assets over the course of the past months has also resulted in an increased demand...

Solar Integrated Roofing Corp (OTCMKTS:SIRC) Surges Higher On Sector Strength

The Solar Integrated Roofing Corp (OTCMKTS:SIRC) stock has come into sharp focus among investors and on Wednesday, the stock made significant gains...

Over the course of the year so far many companies have come into focus among investors due to its work on products meant for tackling the coronavirus pandemic and one such company is CytoDyn Inc (OTCMKTS:CYDY).

Over the course of the past week the CytoDyn stock has come back into focus among investors following a major development.

Key Developments

The stock has rallied by as much as 50% over the course of the past week and it could be worthwhile for investors to perhaps take a closer look at the latest news.

The company’s product leronlimab, which is also being tested as a treatment for COVID 19 patients, is at the centre of the latest developments.

Last Thursday, the company that it successfully enrolled the very first patient for the Phase 2 study of leronlimab as a potential treatment of NASH (nonalcoholic steatohepatitis). NASH is a well known and chronic condition of the liver. The preclinical study that has been conducted into leronlimab has shown that it could help in the treatment of NAFLD (nonalcoholic fatty liver disease).

That is a significant update considering the fact that NASH is often preceded by NASH in patients. This particular update may have been the main reason behind the renewed interest in the stock this past week.

The possibility of using leronlimab for treating patients suffering from coronavirus infection has also proven to be a major trigger for the stock. Over the course of 2020 so far, the stock has rallied by as much as 147% and that is particularly notable since, during the same period, the rest of the industry has recorded a 2% decline.

The results of the Phase 2 study into the possibility of leronlimab as a treatment for COVID 19 produced positive results as well. In this regard, it is also necessary to point out that CytoDyn is also trying to develop leronlimab as a potential treatment for different forms of cancer.

Disclaimer: We hold no position in CYDY stock.

Latest article

American Diversified Holdings Corp (OTCMKTS:ADHC) Nears Critical Level

When a stock records significant gains and then crashes and repeats over the course of a few months, then it might be...

Reconnaissance Energy Africa Ltd (OTCMKTS:RECAF) Gathers Further Momentum

If you are currently looking for stocks that may have recorded massive gains within a short period of time, then it might...

Is Tilray Inc (NASDAQ:TLRY) Stock a Good Buy After The Recent Fall?

The cannabis sector may have had a hard time not too long ago but over the course of the past months, the...

Sysorex Inc (OTCMKTS:SYSX) Stock Still Riding Big News

Investors are always drawn to stocks that make a big jump out of nowhere. So it's no surprise that Sysorex Inc (OTCMKTS:SYSX)...

BIGG Digital Assets Inc (OTCMKTS:BBKCF) is Struggling to Regain Momentum

Over the course of the past few months, the continued rally in some of the biggest cryptocurrencies has led to considerable interest...
Şehirler arası nakliyat ve Şehirler arası taşımacılık konusunda en uygun fiyatlar ve en kaliteli hizmet.
ofis taşıma firmaları ve ofis taşıma konusunda en uygun fiyatlar ve en kaliteli hizmet. Affordable best sms verification service